Landscapes / Companies
Immorna Biotherapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials · 4 in all
Trials
4 active
8 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 30 Mar 2028Phase 1/2 trial completes | |||
| Next date | 30 Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Malignant Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 2 | Mar 2028Phase 1 trial completes | |||
| Next date | Mar 2028 · Phase 1 trial completes | ||||
| Also tested for | Herpes Zoster (HZ), Infectious Diseases and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Respiratory Syncytial Virus (RSV), Infectious Disease | ||||
| Open drug page | |||||
About
- No active trial
- JCXH-221
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021